Psychemedics Statistics
Total Valuation
Psychemedics has a market cap or net worth of $13.51 million. The enterprise value is $13.92 million.
Important Dates
The last earnings date was Tuesday, August 13, 2024, after market close.
| Earnings Date | Aug 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Psychemedics has 5.82 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Shares Outstanding | 5.82M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 20.60% |
| Owned by Institutions (%) | 21.18% |
| Float | 4.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| Forward PS | n/a |
| PB Ratio | 2.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.60 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.83 |
Financial Efficiency
Return on equity (ROE) is -61.33% and return on invested capital (ROIC) is -21.82%.
| Return on Equity (ROE) | -61.33% |
| Return on Assets (ROA) | -16.24% |
| Return on Capital (ROIC) | -21.82% |
| Revenue Per Employee | $179,198 |
| Profits Per Employee | -$39,302 |
| Employee Count | 116 |
| Asset Turnover | 1.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Psychemedics has paid $1.11 million in taxes.
| Income Tax | 1.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.49% in the last 52 weeks. The beta is 0.68, so Psychemedics's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -40.49% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 2.69 |
| Relative Strength Index (RSI) | 56.56 |
| Average Volume (20 Days) | 43,267 |
Short Selling Information
The latest short interest is 20,873, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 20,873 |
| Short Previous Month | 30,092 |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 0.72 |
Income Statement
In the last 12 months, Psychemedics had revenue of $20.79 million and -$4.56 million in losses. Loss per share was -$0.79.
| Revenue | 20.79M |
| Gross Profit | 7.82M |
| Operating Income | -3.44M |
| Pretax Income | -3.48M |
| Net Income | -4.56M |
| EBITDA | -2.24M |
| EBIT | -3.44M |
| Loss Per Share | -$0.79 |
Full Income StatementBalance Sheet
The company has $1.43 million in cash and $1.87 million in debt, giving a net cash position of -$434,000 or -$0.07 per share.
| Cash & Cash Equivalents | 1.43M |
| Total Debt | 1.87M |
| Net Cash | -434,000 |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | 5.74M |
| Book Value Per Share | 0.99 |
| Working Capital | 2.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$649,000 and capital expenditures -$161,000, giving a free cash flow of -$810,000.
| Operating Cash Flow | -649,000 |
| Capital Expenditures | -161,000 |
| Free Cash Flow | -810,000 |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
Gross margin is 37.63%, with operating and profit margins of -16.56% and -21.93%.
| Gross Margin | 37.63% |
| Operating Margin | -16.56% |
| Pretax Margin | -16.61% |
| Profit Margin | -21.93% |
| EBITDA Margin | -10.78% |
| EBIT Margin | -16.56% |
| FCF Margin | -8.58% |